SPDR S&P Biotech ETF $XBI Shares Acquired by Firethorn Wealth Partners LLC

Firethorn Wealth Partners LLC increased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,213 shares of the exchange traded fund’s stock after acquiring an additional 615 shares during the period. Firethorn Wealth Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $847,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Provident Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 3,000.0% in the first quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock valued at $25,000 after buying an additional 300 shares during the period. DHJJ Financial Advisors Ltd. purchased a new position in SPDR S&P Biotech ETF in the second quarter valued at approximately $25,000. Garrison Bradford & Associates Inc. purchased a new position in SPDR S&P Biotech ETF in the first quarter valued at approximately $39,000. Compass Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 46.0% in the first quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after buying an additional 200 shares during the period. Finally, Golden State Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after buying an additional 319 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $103.60 on Friday. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47. The company’s 50 day moving average price is $92.10 and its 200 day moving average price is $85.15. The firm has a market capitalization of $5.91 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.